Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 562,630 | 487,130 | -75,500 | $105.37M | $99.99M | 21.36% | -$5.38M |
| AtriCure, Inc.(ATRC) | 597,431 | 522,747 | -74,684 | $16.72M | $29.38M | 6.28% | +$12.66M |
| COMPASS Pathways plcADS(CMPS) | 2,011,952 | 2,135,952 | +124,000 | $28.47M | $26.57M | 5.68% | -$1.90M |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 196,505 | 151,505 | -45,000 | $31.10M | $23.89M | 5.10% | -$7.21M |
| Nektar Therapeutics(NKTR) | 318,380 | 323,380 | +5,000 | $22.23M | $19.58M | 4.18% | -$2.65M |
| IDEAYA Biosciences, Inc.(IDYA) | 497,240 | 438,740 | -58,500 | $18.53M | $16.86M | 3.60% | -$1.68M |
| Stereotaxis Inc | 13,680,554 | 13,680,554 | 0 | $23.53M | $16.83M | 3.60% | -$6.70M |
| Denali Therapeutics Inc.(DNLI) | 739,014 | 744,014 | +5,000 | $19.01M | $15.38M | 3.29% | -$3.63M |
| Ascendis Pharma A/S(ASND) | 48,469 | 49,969 | +1,500 | $12.93M | $11.38M | 2.43% | -$1.54M |
| Arcus Biosciences, Inc.(RCUS) | 441,829 | 439,829 | -2,000 | $13.62M | $11.36M | 2.43% | -$2.26M |
| Cytokinetics, Incorporated(CYTK) | 171,998 | 171,998 | 0 | $14.65M | $11.34M | 2.42% | -$3.32M |
| Edgewise Therapeutics, Inc.(EWTX) | 226,819 | 221,819 | -5,000 | $9.22M | $9.01M | 1.92% | -$209.8K |
| Neurocrine Biosciences, Inc.(NBIX) | 57,769 | 62,716 | +4,947 | $9.74M | $8.90M | 1.90% | -$840.5K |
| Insulet Corporation(PODD) | 61,870 | 67,870 | +6,000 | $9.42M | $8.85M | 1.89% | -$564.7K |
| Xenon Pharmaceuticals Inc.(XENE) | 250,772 | 204,772 | -46,000 | $15.14M | $7.62M | 1.63% | -$7.52M |
| Axogen, Inc.(AXGN) | 208,960 | 179,960 | -29,000 | $9.65M | $7.54M | 1.61% | -$2.11M |
| DexCom, Inc.(DXCM) | 86,279 | 86,279 | 0 | $5.81M | $7.45M | 1.59% | +$1.63M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 335,255 | 331,290 | -3,965 | $7.33M | $6.23M | 1.33% | -$1.10M |
| Larimar Therapeutics Inc | 2,008,164 | 1,888,155 | -120,009 | $6.12M | $6.03M | 1.29% | -$92.2K |
| Tandem Diabetes Care, Inc.(TNDM) | 355,208 | 355,208 | 0 | $5.36M | $5.79M | 1.24% | +$433.4K |
| Bicara Therapeutics Inc | 284,955 | 299,955 | +15,000 | $8.46M | $5.58M | 1.19% | -$2.88M |
| Rapport Therapeutics, Inc.(RAPP) | 75,000 | 141,900 | +66,900 | $3.13M | $4.77M | 1.02% | +$1.64M |
| Immunovant, Inc.(IMVT) | 149,524 | 135,524 | -14,000 | $5.76M | $4.58M | 0.98% | -$1.18M |
| Inogen Inc | 845,179 | 845,179 | 0 | $5.45M | $4.45M | 0.95% | -$997.3K |
| Neurogene Inc | 89,032 | 150,532 | +61,500 | $2.80M | $4.19M | 0.89% | +$1.39M |
| Alkermes plcSHS(ALKS) | 101,266 | 101,266 | 0 | $5.31M | $4.10M | 0.88% | -$1.20M |
| Century Therapeutics Inc | 2,400,458 | 2,386,750 | -13,708 | $5.88M | $4.08M | 0.87% | -$1.80M |
| OrthoPediatrics Corp.(KIDS) | 189,130 | 179,130 | -10,000 | $3.62M | $3.99M | 0.85% | +$371.2K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $3.90M | $3.86M | 0.82% | -$43.0K |
| Stoke Therapeutics, Inc.(STOK) | 130,875 | 146,135 | +15,260 | $4.28M | $3.80M | 0.81% | -$482.7K |
| Adlai Nortye Group LtdADS | 239,553 | 232,763 | -6,790 | $2.75M | $3.72M | 0.80% | +$969.3K |
| Eupraxia Pharmaceuticals Inc | 225,600 | 404,567 | +178,967 | $1.49M | $3.68M | 0.79% | +$2.19M |
| Celldex Therapeutics, Inc.(CLDX) | 68,518 | 108,118 | +39,600 | $2.55M | $3.50M | 0.75% | +$954.5K |
| Allogene Therapeutics Inc | 2,000,000 | 2,000,000 | 0 | $4.16M | $3.20M | 0.68% | -$960.0K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 400,248 | 380,248 | -20,000 | $4.00M | $3.17M | 0.68% | -$835.0K |
| Kymera Therapeutics, Inc.(KYMR) | 27,000 | 26,912 | -88 | $3.10M | $3.01M | 0.64% | -$87.6K |
| Aquestive Therapeutics Inc | 645,915 | 640,915 | -5,000 | $2.69M | $2.97M | 0.63% | +$280.4K |
| Atrium Therapeutics Inc | 128,000 | 300,076 | +172,076 | $1.72M | $2.48M | 0.53% | +$763.0K |
| Ishares Nasdaq Biotech IndxETF | 42,595 | 11,595 | -31,000 | $8.10M | $2.44M | 0.52% | -$5.66M |
| PROCEPT BioRobotics Corporation(PRCT) | 120,000 | 120,000 | 0 | $2.71M | $2.19M | 0.47% | -$523.2K |
| Proqr Therapeutics NvSHS EURO SHS EURO | 1,530,361 | 1,312,530 | -217,831 | $2.85M | $2.18M | 0.47% | -$667.7K |
| Cybin Inc | 514,061 | 175,702 | -338,359 | $3.40M | $2.16M | 0.46% | -$1.24M |
| Align Technology Inc | 14,000 | 14,000 | 0 | $2.36M | $2.03M | 0.43% | -$326.3K |
| Viking Therapeutics, Inc.(VKTX) | 59,516 | 54,516 | -5,000 | $2.32M | $1.78M | 0.38% | -$544.5K |
| Maze Therapeutics, Inc.(MAZE) | 65,000 | 65,000 | 0 | $1.94M | $1.77M | 0.38% | -$172.9K |
| Alector Inc | 908,351 | 908,351 | 0 | $1.83M | $1.68M | 0.36% | -$145.3K |
| Tela Bio Inc | 1,441,029 | 1,441,029 | 0 | $1.08M | $1.66M | 0.35% | +$576.4K |
| Maplight Therapeutics Inc | 171,006 | 155,579 | -15,427 | $6.13M | $1.59M | 0.34% | -$4.54M |
| Nervgen Pharma Corp | 1,050,000 | 810,862 | -239,138 | $2.16M | $1.55M | 0.33% | -$614.3K |
| Structure Therapeutics IncADS | 46,500 | 46,500 | 0 | $2.50M | $1.45M | 0.31% | -$1.04M |
| Profound Medical Corp | 260,360 | 225,094 | -35,266 | $1.73M | $1.31M | 0.28% | -$425.8K |
| Mediwound LtdSHS NEW | 94,405 | 94,405 | 0 | $1.39M | $1.30M | 0.28% | -$87.8K |
| Design Therapeutics Inc | 102,600 | 102,100 | -500 | $1.48M | $1.28M | 0.27% | -$201.2K |
| Lexeo Therapeutics Inc | 377,059 | 377,059 | 0 | $1.76M | $1.27M | 0.27% | -$480.8K |
| Inspire Medical Systems, Inc.(INSP) | 18,200 | 18,200 | 0 | $811.9K | $1.26M | 0.27% | +$450.4K |
| Cytomx Therapeutics Inc | 438,407 | 438,407 | 0 | $1.64M | $1.19M | 0.25% | -$451.6K |
| Fate Therapeutics Inc | 525,000 | 500,000 | -25,000 | $1.42M | $1.19M | 0.25% | -$232.5K |
| Mineralys Therapeutics, Inc.(MLYS) | 44,490 | 44,490 | 0 | $1.20M | $1.12M | 0.24% | -$82.3K |
| Polypid Ltd | 207,900 | 207,900 | 0 | $1.06M | $1.10M | 0.23% | +$39.5K |
| Bridgebio Oncology Therapeutics | 0 | 266,038 | +266,038 | $0 | $1.09M | 0.23% | +$1.09M |
| Annexon Inc | 297,812 | 257,637 | -40,175 | $1.70M | $1.09M | 0.23% | -$610.7K |
| Biohaven Ltd.(BHVN) | 137,593 | 77,593 | -60,000 | $2.05M | $1.04M | 0.22% | -$1.01M |
| Immatics N.V.SHS(IMTX) | 116,960 | 116,960 | 0 | $1.18M | $1.03M | 0.22% | -$157.9K |
| Q32 Bio Inc | 32,896 | 98,500 | +65,604 | $419.1K | $814.6K | 0.17% | +$395.5K |
| Pyxis Oncology Inc | 0 | 344,820 | +344,820 | $0 | $803.4K | 0.17% | +$803.4K |
| Ars Pharmaceuticals Inc | 164,285 | 182,785 | +18,500 | $1.32M | $787.8K | 0.17% | -$528.1K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 47,100 | 51,100 | +4,000 | $1.57M | $768.0K | 0.16% | -$804.6K |
| Kura Oncology Inc | 120,568 | 69,068 | -51,500 | $1.32M | $739.7K | 0.16% | -$582.9K |
| BioNTech SEADS(BNTX) | 7,000 | 7,000 | 0 | $651.4K | $688.1K | 0.15% | +$36.8K |
| Scynexis Inc | 135,868 | 135,868 | 0 | $553.0K | $671.2K | 0.14% | +$118.2K |
| Adicet Bio Inc | 93,812 | 93,812 | 0 | $810.5K | $669.8K | 0.14% | -$140.7K |
| Seaport Therapeutics Inc | 32,400 | 32,400 | 0 | $703.7K | $653.5K | 0.14% | -$50.2K |
| Quoin Pharmaceuticals LtdADS | 0 | 132,156 | +132,156 | $0 | $602.6K | 0.13% | +$602.6K |
| Corbus Pharmaceuticals Hldgs | 107,773 | 83,248 | -24,525 | $1.01M | $567.8K | 0.12% | -$443.2K |
| Pliant Therapeutics Inc | 487,000 | 487,000 | 0 | $555.2K | $526.0K | 0.11% | -$29.2K |
| Editas Medicine Inc | 170,470 | 180,470 | +10,000 | $552.3K | $463.8K | 0.10% | -$88.5K |
| Accuray Inc | 1,680,508 | 1,680,508 | 0 | $433.2K | $453.9K | 0.10% | +$20.7K |
| Compugen Ltd | 168,232 | 168,232 | 0 | $360.0K | $400.4K | 0.09% | +$40.4K |
| Autolus Therapeutics LtdADS | 179,316 | 179,316 | 0 | $286.9K | $347.9K | 0.07% | +$61.0K |
| Foghorn Therapeutics Inc | 111,859 | 89,659 | -22,200 | $545.9K | $320.1K | 0.07% | -$225.8K |
| Ibio Inc | 170,053 | 170,053 | 0 | $297.6K | $200.7K | 0.04% | -$96.9K |
| Tenaya Therapeutics Inc | 300,000 | 300,000 | 0 | $221.7K | $181.1K | 0.04% | -$40.6K |
| Kazia Therapeutics LtdADS | 0 | 15,700 | +15,700 | $0 | $150.6K | 0.03% | +$150.6K |
| Engene Therapeutics Inc | 74,650 | 74,650 | 0 | $129.1K | $149.3K | 0.03% | +$20.2K |
| Verrica Pharmaceuticals Inc | 23,750 | 23,750 | 0 | $145.3K | $113.9K | 0.02% | -$31.5K |
| Kardigan Inc | 5,000 | 5,000 | 0 | $119.3K | $73.8K | 0.02% | -$45.5K |
| Adc Therapeutics SaSHS | 77,081 | 57,081 | -20,000 | $82.5K | $69.6K | 0.01% | -$12.8K |
| Artiva Biotherapeutics, Inc.(ARTV) | 67,101 | 0 | -67,101 | $650.9K | $0 | — | -$650.9K |
| Bicycle Therapeutics PlcADS | 64,492 | 0 | -64,492 | $273.4K | $0 | — | -$273.4K |
| MBX Biosciences, Inc.(MBX) | 11,809 | 0 | -11,809 | $651.9K | $0 | — | -$651.9K |
| Nuvectis Pharma, Inc.(NVCT) | 20,000 | 0 | -20,000 | $367.8K | $0 | — | -$367.8K |
| Orchestra BioMed Holdings, Inc.(OBIO) | 126,841 | 0 | -126,841 | $547.3K | $0 | — | -$547.3K |